Impel NeuroPharma’s $80 Million Initial Public Offering

Martina Bellini North America, North America Legal Chronicle
Tagged:

Fenwick & West LLP advised Impel NeuroPharma on the deal.Impel NeuroPharma, a late-stage pharmaceutical company developing transformative therapies for diseases of the central nervous system, announced its initial…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here